Theranostic strategy against plaque angiogenesis.
Arbustini
Eloisa
E
Gambarin
Fabiana Isabella
FI
D020533:Angiogenesis Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D000069059:Atorvastatin; D002232:Carbocyanines / Q000378:metabolism; D003510:Cyclohexanes / Q000378:metabolism / Q000494:pharmacology*; D004337:Drug Carriers; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005231:Fatty Acids, Unsaturated / Q000378:metabolism / Q000494:pharmacology*; D006538:Heptanoic Acids / Q000494:pharmacology; D006573:Heterocyclic Compounds, 1-Ring / Q000378:metabolism; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D053758:Nanoparticles; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D011758:Pyrroles / Q000494:pharmacology; D012717:Sesquiterpenes / Q000378:metabolism / Q000494:pharmacology; D013997:Time Factors
D020533:Angiogenesis Inhibitors; D002232:Carbocyanines; D003510:Cyclohexanes; D004337:Drug Carriers; D005231:Fatty Acids, Unsaturated; D006538:Heptanoic Acids; D006573:Heterocyclic Compounds, 1-Ring; D039302:Integrin alphaVbeta3; D011758:Pyrroles; D012717:Sesquiterpenes; C494049:TA 145; C026211:fumagillin; D000069059:Atorvastatin